methyldopa has been researched along with Premature Birth in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Khalaf, S; Chappell, LC; Khashan, AS; McCarthy, FP; O'Reilly, ÉJ | 1 |
| Avalos, LA; Badon, SE; Bider-Canfield, Z; Cheetham, TC; Chen, L; Dublin, S; Easterling, TR; Holt, VL; Idu, A; Nance, N; Neugebauer, RS; Reynolds, K; Shortreed, SM | 1 |
| Shigemi, D; Taguchi, R; Yasunaga, H | 1 |
| Battarbee, AN; Harper, LM; Oparil, S; Sinkey, RG; Tita, ATN | 1 |
| Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
| Beck, E; Fietz, AK; Hoeltzenbein, M; Kayser, A; Meister, R; Padberg, S; Schaefer, C; Weber-Schoendorfer, C; Wernicke, J; Zinke, S | 1 |
| Ahmed, B; Havard, A; Jorm, LR; Kennedy, SE; Tran, DT; Zoega, H | 1 |
| Chattopadhyay, S; Das, A; Pahari, S | 1 |
| Asztalos, E; Gafni, A; Ganzevoort, JW; Gruslin, A; Helewa, M; Hutton, E; Koren, G; Lee, SK; Lee, T; Logan, AG; Magee, LA; Menzies, J; Moutquin, JM; Murphy, KE; Rey, E; Ross, S; Sanchez, J; Singer, J; Thornton, JG; von Dadelszen, P; Welch, R | 1 |
| Jabeen, F; Malik, AR; Mir, S; Molvi, SN; Rana, VS | 1 |
2 review(s) available for methyldopa and Premature Birth
| Article | Year |
|---|---|
Chronic hypertension in pregnancy.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Cesarean Section; Chronic Disease; Delivery, Obstetric; Disease Management; Female; Fetal Growth Retardation; Gestational Age; Humans; Hypertension; Long-Acting Reversible Contraception; Methyldopa; Postnatal Care; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prenatal Care; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Vasodilator Agents | 2020 |
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
3 trial(s) available for methyldopa and Premature Birth
| Article | Year |
|---|---|
Fetomaternal outcome in severe preeclamptic women undergoing emergency cesarean section under either general or spinal anesthesia.
Topics: Adolescent; Adult; Anesthesia, General; Anesthesia, Spinal; Anticonvulsants; Antihypertensive Agents; Apgar Score; Cesarean Section; Female; Fetal Mortality; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Labetalol; Magnesium Sulfate; Maternal Mortality; Methyldopa; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Seizures; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Decision-Making; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Low Birth Weight; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prenatal Care; Risk Factors; Treatment Outcome | 2016 |
Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
Topics: Adult; Antihypertensive Agents; Cesarean Section; Female; Humans; Hypertension, Pregnancy-Induced; Incidence; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Methyldopa; Pregnancy; Premature Birth; Proteinuria; Severity of Illness Index; Treatment Outcome; Young Adult | 2012 |
5 other study(ies) available for methyldopa and Premature Birth
| Article | Year |
|---|---|
Role of Antihypertensive Treatment and Blood Pressure Control in the Occurrence of Adverse Pregnancy Outcomes: a Population-Based Study of Linked Electronic Health Records.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Electronic Health Records; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Premature Birth | 2022 |
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Topics: Antihypertensive Agents; Birth Weight; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies | 2022 |
Trends in antihypertensive prescription for pregnant women with hypertension and their peripartum outcomes before and after label and guideline revisions in Japan.
Topics: Antihypertensive Agents; Cesarean Section; Drug Prescriptions; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Japan; Methyldopa; Nifedipine; Peripartum Period; Pregnancy; Pregnancy Outcome; Pregnant Women; Premature Birth; Retrospective Studies | 2022 |
Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study.
Topics: Abortion, Spontaneous; Adult; Antihypertensive Agents; Congenital Abnormalities; Female; Germany; Humans; Hypertension; Infant, Low Birth Weight; Methyldopa; Pharmacovigilance; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies; Risk Assessment | 2017 |
Maternal and perinatal outcomes associated with the use of renin-angiotensin system (RAS) blockers for chronic hypertension in early pregnancy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cesarean Section; Cohort Studies; Female; Humans; Hypertension; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Methyldopa; Pregnancy; Pregnancy Trimester, First; Premature Birth | 2018 |